Jazz Pharmaceuticals plc

NASDAQ:JAZZ  
153.65
+2.48 (+1.64%)
Other Pre-Announcement

Jazz Pharmaceuticals Announces Second Quarter 2022 Financial Results And Affirms 2022 Financial Guidance

Published: 08/03/2022 21:53 GMT
Jazz Pharmaceuticals plc (JAZZ) - Jazz Pharmaceuticals Announces Second Quarter 2022 Financial Results and Affirms 2022 Financial Guidance.
Q2 Revenue Rose 24 Percent to $932.9 Million.
2022 Total Revenue Guidance Affirmed at $3.5 to $3.7 Billion.
Q2 Revenue View $904.2 Million -- Refinitiv Ibes Data (analyst estimates).
FY2022 Revenue View $3.60 Billion -- Refinitiv Ibes Data (analyst estimates).
Qtrly GAAP EPS $ 0.55.
Qtrly Adjusted EPS $4.30.
Q2 Earnings per Share View $4.19 -- Refinitiv Ibes Data (analyst estimates).